Evidence map›Paper›PMID 34538668›Full record

ArticleRevue neurologique

CONFISEP: Impact of the Covid-19 pandemic lockdown on patients with multiple sclerosis in the north of France.

C Donzé, C Massot, A Kwiatkowski, M Guenot, P Hautecoeur

Open access · greenAbstract read
In one paragraph

Article in Revue neurologique. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

C DonzéFaculté de médecine et de maïeutique de Lille, service de médecine physique et réadaptation; hôpital Saint-Philibert, groupement des hôpitaux de l'institut catholique de Lille, Lomme, France. Electronic address: donze.cecile@ghicl.net.
C MassotFaculté de médecine et de maïeutique de Lille, service de médecine physique et réadaptation; hôpital Saint-Philibert, groupement des hôpitaux de l'institut catholique de Lille, Lomme, France.
A KwiatkowskiFaculté de médecine et de maïeutique de Lille, service de neurologie; hôpital Saint-Vincent de Paul, groupement des hôpitaux de l'institut catholique de Lille, Lomme, France.
M GuenotFaculté de médecine et de maïeutique de Lille, service de médecine physique et réadaptation; hôpital Saint-Philibert, groupement des hôpitaux de l'institut catholique de Lille, Lomme, France.
P HautecoeurFaculté de médecine et de maïeutique de Lille, service de neurologie; hôpital Saint-Vincent de Paul, groupement des hôpitaux de l'institut catholique de Lille, Lomme, France.
Groupe Hospitalier de l'Institut Catholique de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed an online survey to assess lockdown impact in 176 patients with multiple sclerosis (PwMS) in the north of France. Access to healthcare was reduced for 38% of PwMS, mainly in physiotherapy, general practitioners and neurologists. 49.2% have implemented self-rehabilitation programs. Medical support was maintained for 39.2% through teleconsultations. 76.2% reported a negative impact of lockdown related to worsen disability. 45.5% expressed beneficial effects like strengthening family relationships, and reduced fatigue. Previous studies have found the same results on disability and discontinuation of care. However, even if this period has been challenging for PwMS, most of them have shown excellent adaptability.

Indexed as

COVID-19Multiple SclerosisCommunicable Disease ControlFranceHumansPandemicsSARS-CoV-2Covid-19ImpactLockdownMultiple sclerosis

Identifiers

PMID34538668
PMCPMC8433045
OpenAlexW3199631603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.